Polymersomes Eradicating Intracellular Bacteria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32515944.
- Also identified by DOI 10.1021/acsnano.0c01870 and PMC identifier 7618071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mononuclear phagocytes such as monocytes, tissue-specific macrophages, and dendritic cells are primary actors in both innate and adaptive immunity. These professional phagocytes can be parasitized by intracellular bacteria, turning them from housekeepers to hiding places and favoring chronic and/or disseminated infection. One of the most infamous is the bacteria that cause tuberculosis (TB), which is the most pandemic and one of the deadliest diseases, with one-third of the world's population infected and an average of 1.8 million deaths/year worldwide. Here we demonstrate the effective targeting and intracellular delivery of antibiotics to infected macrophages both <i>in vitro</i> and <i>in vivo</i>, using pH-sensitive nanoscopic polymersomes made of PMPC-PDPA block copolymer. Polymersomes showed the ability to significantly enhance the efficacy of the antibiotics killing <i>Mycobacterium bovis</i>, <i>Mycobacterium tuberculosis</i>, and another established intracellular pathogen, <i>Staphylococcus aureus</i>. Moreover, they demonstrated to easily access TB-like granuloma tissues-one of the harshest environments to penetrate-in zebrafish models. We thus successfully exploited this targeting for the effective eradication of several intracellular bacteria, including <i>M. tuberculosis</i>, the etiological agent of human TB.
Medical subject headings
- Mycobacterium tuberculosis
- Tuberculosis